Document 2qD3Qy9oR6OVQ9M98jy1Lek5g

f THE UPJOHN COMPANY K A LA M A ZO O , M IC HIG A N 49001 TELEPHONE (616) 382-4000 M EDICAL SERVICES Office of KENNETH B HAAS D V M July 13, 1976 Hearing Clerk Food and Drug Administration Room h-SS 5600 Fishers Lane Rockville, Maryland 20852 Dear Sir: In compliance with the Federal Register Notice, Volume 40, Number 51, March lA, 1975, page 11865, titled "Asbestos-form Particles in Drugs for Parenteral Injection", we are supplying the attached memo as an updated report for replacement of asbestos filters. Very truly yours, THE UPJOHN COMPANY HRA/KBH/ct att. Harry R. Allen, M.D. Manager, FDA Liaison Domestic Pharmaceutical Medical Affairs $u p o if %I Stability is continuing on the two lots of S.A.S. Diurnal Penicillin Readimixed which were, described in earlier reports. Three months' f. data should be available at the end of August. |. r~ ii if i- V1 lad